CEO: Neal S. Walker
Employees: 61
IPO: Oct 06, 2015
السعر
KWD 4.20
التغيير
▲ KWD 0.06
1.45%
القيمة السوقية
506.50M
نطاق اليوم
KWD 4.01
KWD 4.22
نطاق 52 أسبوعًا
KWD 1.05
KWD 4.89
حجم التداول
892,765
متوسط 50 يوم / 200 يوم
KWD 3.52
KWD 2.49
الإغلاق السابق
KWD 4.14
Quick Summary
النقاط الرئيسية
Revenue grew 3.72% annually over 5 years — modest growth
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -47.11M
PEG of 0.08 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 61.91%
Capital efficient — spends only 1.42% of revenue on capex
النمو
Revenue Growth (5Y)
3.72%
أقل من متوسط القطاع (9.58%)
Revenue (1Y)-58.19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-50.20%
أقل من متوسط القطاع (3.46%)
ROIC-54.45%
Net Margin-829.58%
Op. Margin-975.91%
الأمان
Debt / Equity
0.02
أقل من متوسط القطاع (0.23)
Current Ratio5.28
Interest Coverage0.00
التقييم
P/E Ratio
-7.80
أقل من متوسط القطاع (0.22)
Forward P/EN/A
P/B Ratio4.91
EV/EBITDAN/A
Dividend Yield0.00%
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (640 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -7.8 | 0.2 |
| P/B | 4.9 | 2.9 |
| ROE % | -50.2 | 3.5 |
| Net Margin % | -829.6 | 3.9 |
| Rev Growth 5Y % | 3.7 | 9.6 |
| D/E | 0.0 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -58.19% | Revenue Growth (3Y) | -49.96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3.72% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7.83M | Net Income (TTM) | -64.92M |
| ROE | -50.20% | ROA | -40.46% |
| Gross Margin | 73.28% | Operating Margin | -975.91% |
| Net Margin | -829.58% | Free Cash Flow (TTM) | -47.11M |
| ROIC | -54.45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 5.28 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7.80 | Forward P/E | N/A |
| P/B Ratio | 4.91 | P/S Ratio | 64.72 |
| PEG Ratio | 0.08 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -9.30% | ||
| Market Cap | 506.50M | Enterprise Value | 488.66M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.83M | 18.72M | 31.25M | 29.75M | 6.76M |
| Net Income | -64.92M | -132.07M | -88.48M | -86.91M | -90.87M |
| EPS (Diluted) | -0.53 | -1.71 | -1.27 | -1.33 | -1.60 |
| Gross Profit | 5.74M | 15.93M | 13.17M | 17.79M | 2.05M |
| Operating Income | -76.38M | -141.93M | -97.36M | -89.85M | -89.72M |
| EBITDA | -64.47M | -51.72M | -115.45M | -84.36M | -64.46M |
| R&D Expenses | 52.65M | 33.59M | 98.38M | 77.81M | 43.81M |
| SG&A Expenses | 21.97M | 22.20M | 31.10M | 25.13M | 23.62M |
| D&A | 454,000.0 | 807,000.0 | 863,000.0 | 797,000.0 | 923,000.0 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Income Tax | 0.0 | 0.0 | -367,000.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 160.46M | 220.33M | 197.41M | 254.60M | 251.21M |
| Total Liabilities | 57.38M | 64.77M | 40.23M | 56.98M | 53.87M |
| Shareholders' Equity | 103.08M | 155.55M | 157.18M | 197.62M | 197.34M |
| Total Debt | 2.12M | 0.0 | 426,000.0 | 684,000.0 | 693,000.0 |
| Cash & Equivalents | 19.96M | 24.57M | 39.88M | 45.28M | 27.35M |
| Current Assets | 151.36M | 125.95M | 128.86M | 231.55M | 205.03M |
| Current Liabilities | 28.65M | 31.60M | 30.95M | 21.94M | 22.93M |